Homology Medicines Inc

NASDAQ:FIXX   3:59:32 PM EDT
9.62
+0.02 (+0.16%)
Earnings Announcements

Homology Medicines Reports Q3 2020 Financial Results

Published: 11/09/2020 22:26 GMT
Homology Medicines Inc (FIXX) - Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights.
Q3 Loss per Share $0.62.
Q3 Earnings per Share Estimate $-0.80 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Collaboration Revenue $567,000 Versus $441,000.
Q3 Revenue View $482000.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.59 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0.6 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.